Affinity proteomics within rare diseases: a BIO‐NMD study for blood biomarkers of muscular dystrophies
Open Access
- 11 June 2014
- journal article
- Published by Springer Nature in EMBO Molecular Medicine
- Vol. 6 (7) , 918-936
Abstract
Despite the recent progress in the broad‐scaled analysis of proteins in body fluids, there is still a lack in protein profiling approaches for biomarkers of rare diseases. Scarcity of samples is the main obstacle hindering attempts to apply discovery driven protein profiling in rare diseases. We addressed this challenge by combining samples collected within the BIO‐NMD consortium from four geographically dispersed clinical sites to identify protein markers associated with muscular dystrophy using an antibody bead array platform with 384 antibodies. Based on concordance in statistical significance and confirmatory results obtained from analysis of both serum and plasma, we identified eleven proteins associated with muscular dystrophy, among which four proteins were elevated in blood from muscular dystrophy patients: carbonic anhydrase III (CA3) and myosin light chain 3 (MYL3), both specifically expressed in slow‐twitch muscle fibers and mitochondrial malate dehydrogenase 2 (MDH2) and electron transfer flavoprotein A (ETFA). Using age‐matched sub‐cohorts, 9 protein profiles correlating with disease progression and severity were identified, which hold promise for the development of new clinical tools for management of dystrophinopathies.Keywords
Funding Information
- European Community Framework Programme 7 (241665)
- ProNova VINN Excellence Centre for Protein Technology
- Innovation Systems
- the Knut and Alice Wallenberg Foundation
- Medical Research Scotland
- TREAT‐NMD (036825)
This publication has 75 references indexed in Scilit:
- Comparison of serum, EDTA plasma and P100 plasma for luminex-based biomarker multiplex assays in patients with chronic obstructive pulmonary disease in the SPIROMICS studyJournal of Translational Medicine, 2014
- 24 Month Longitudinal Data in Ambulant Boys with Duchenne Muscular DystrophyPLOS ONE, 2013
- High-resolution Mapping of Linear Antibody Epitopes Using Ultrahigh-density Peptide MicroarraysMolecular & Cellular Proteomics, 2012
- Muscle carbonic anhydrase III levels in normal and muscular dystrophia afflicted chickensActa Veterinaria Scandinavica, 2012
- Novel Approach to Meta-Analysis of Microarray Datasets Reveals Muscle Remodeling-related Drug Targets and Biomarkers in Duchenne Muscular DystrophyPLOS Computational Biology, 2012
- Creatine-Kinase- and Exercise-Related Muscle Damage Implications for Muscle Performance and RecoveryJournal of Nutrition and Metabolism, 2012
- miRNAs as serum biomarkers for Duchenne muscular dystrophyEMBO Molecular Medicine, 2011
- Quality Assurance for Duchenne and Becker Muscular Dystrophy Genetic TestingThe Journal of Molecular Diagnostics, 2011
- VennDiagram: a package for the generation of highly-customizable Venn and Euler diagrams in RBMC Bioinformatics, 2011
- Variance decomposition of protein profiles from antibody arrays using a longitudinal twin modelProteome Science, 2011